| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.17 | 1e-06 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.23 | 4e-06 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.17 | 6e-06 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.24 | 1e-05 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.21 | 7e-05 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.0003 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |